Reviewer Acknowledgements 2023

Reviewer Acknowledgements

CONTRIBUTING REVIEWERS The editors of BMC Clinical Pathology would like to thank all of the reviewers who have contributed to the journal in volume 12 (2012).

Reviewer acknowledgements for 2013

The editors of BMC Medicine would like to thank all our reviewers who have contributed to the journal in which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver

BMC Complementary and alternative medicine reviewer acknowledgements, 2014

Dmd053322 2018..2023

In vitro–in vivo correlation (IVIVC) of intrinsic clearance in preclinical species of rat and dog was established using the hepatocyte relay method to support high-confidence prediction of human pharmacokinetics for low-clearance compounds. Good IVIVC of intrinsic clearance was observed for most of the compounds, with predicted values within 2-fold of the observed values. The exceptions involve...

Dmd059675 2023..2032

Cerlapirdine (SAM-531, PF-05212365) is a selective, potent, full antagonist of the 5-hydroxytryptamine 6 (5-HT6) receptor. Cerlapirdine and other 5-HT6 receptor antagonists have been in clinical development for the symptomatic treatment of Alzheimer’s disease. A human absorption, distribution, metabolism, and excretion study was conducted to gain further understanding of the metabolism and disp...